High vs Standard Energy Children's Drink Study

October 30, 2017 updated by: Nutricia UK Ltd

The Effect of Standard Versus High Energy Density, Low Volume Oral Nutritional Supplements in Children Requiring Nutritional Support - a Pilot Trial

This study is a pilot trial investigating the effects of a high energy drink for children, in comparison to standard energy drink for children.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

A four week, multi-centre, randomised controlled trial investigating the effects of a high energy density, low volume oral nutritional supplement versus standard energy density oral nutritional supplements in children aged 1-12yrs old requiring nutritional support. Fifty eligible children will be recruited and randomised to receive either the high energy density oral nutritional supplement or the standard energy density oral nutritional supplement for four weeks. The primary outcome is nutrient intake, with secondary outcomes of compliance, tolerance, acceptability, anthropometry and safety.

Study Type

Interventional

Enrollment (Actual)

51

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 12 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Male or female
  • Aged 1-12yrs
  • Faltering growth and/or requiring oral nutritional supplements to meet nutritional requirements
  • Expected to receive at least one bottle of the study product per day
  • Able to take study products orally during the study period
  • Written informed consent from parent/carer

Exclusion Criteria:

  • Requirement for 100% of their nutrition via enteral tube and/or parenteral feeding.
  • Children with major hepatic or renal dysfunction
  • Children with galactosaemia or severe lactose intolerance
  • Requirement for elemental or semi-elemental feeds
  • Investigator concern around willingness/ability of child/parent/carer to comply with protocol requirements
  • Participation in other studies within 2 weeks of study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A
The group who will receive high energy density, low volume oral nutritional supplement, to be taken for 4 weeks (28 days)
High energy density, low volume oral nutritional supplement (HE ONS) in addition to appropriate nutritional management
Active Comparator: Group B
The group who will receive the standard energy density oral nutritional supplement, to be taken for 4 weeks (28 days)
Standard energy density oral nutritional supplement (SE ONS) in addition to appropriate nutritional management

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nutrient intake
Time Frame: 4 weeks (28 days)
Dietary intake, including the intake of all foods and fluids, will be recorded and analysed throughout the study.
4 weeks (28 days)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Compliance: Compliance with oral nutritional supplements in Group A and Group B; how much of the oral nutritional supplement is taken in comparison to the amount advised by the Dietitian.
Time Frame: 4 weeks (28 days)
4 weeks (28 days)
Tolerance: How well the child tolerates the oral nutritional supplements (including changes to gastrointestinal symptoms)
Time Frame: 4 weeks (28 days)
4 weeks (28 days)
Acceptability: How acceptable the oral nutritional supplement is to the child and their parent/carer, including taste, texture, ease of use, etc.
Time Frame: 4 weeks (28 days)
4 weeks (28 days)
Anthropometry
Time Frame: 4 weeks (28 days)
Changes to weight, height and head circumference in children less than 2yrs of age.
4 weeks (28 days)
Safety assessed by adverse events, to be recorded throughout study.
Time Frame: 4 weeks (28 days)
4 weeks (28 days)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2015

Primary Completion (Actual)

August 1, 2016

Study Completion (Actual)

August 1, 2016

Study Registration Dates

First Submitted

April 14, 2015

First Submitted That Met QC Criteria

April 16, 2015

First Posted (Estimate)

April 17, 2015

Study Record Updates

Last Update Posted (Actual)

November 1, 2017

Last Update Submitted That Met QC Criteria

October 30, 2017

Last Verified

October 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • FC125

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Growth Failure

Clinical Trials on HE ONS

Subscribe